AustinPx Capabilities Overview

Join Dave Miller, Chief Scientific Officer at AustinPx, for an overview of the company’s integrated formulation development, analytical, and clinical manufacturing capabilities for complex oral drug programs. The webinar explores AustinPx’s data-driven approach to preformulation, bioavailability enhancement, dosage form development, and speed-to-clinic manufacturing, including its broad ASD technology toolkit and proprietary KinetiSol™ Technology. Real client case studies demonstrate how tailored formulation strategies can improve performance, reduce development and manufacturing risk, and support scalable paths forward.